LPC
Lion Point Capital Portfolio holdings
AUM
$19.3M
1-Year Est. Return
110.67%
This Fund
S&P 500
1 Year Est. Return
+110.67%
AUM
$17.6M
AUM Growth
+$2.87M
(+20%)
Holding
27
Top Buys
| 1 | +$3.52M | |
| 2 | +$775K | |
| 3 | +$764K | |
| 4 |
Kura Oncology
KURA
|
+$328K |
| 5 |
Day One Biopharmaceuticals
DAWN
|
+$289K |
Top Sells
| 1 | +$938K | |
| 2 | +$865K | |
| 3 | +$731K | |
| 4 |
Fennec Pharmaceuticals
FENC
|
+$629K |
| 5 |
BridgeBio Pharma
BBIO
|
+$619K |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Humacyte
HUMA
$216M
| $145K | 0.83% |
83,500
|
|
||
|
SPRB
27
Spruce Biosciences, Inc. Common Stock
SPRB
$58.8M
| $8.95K | 0.05% |
+1,000
|
|